Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337207
Status:
COMPLETED
Last Update Posted:
2020-02-07
First Post:
2006-06-13
Brief Title:
Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
Sponsor:
Northwestern University
Organization:
Northwestern University
Organization Data
Organization:
Northwestern University
Class:
OTHER
Study ID:
NU 05C3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Northwestern University
Lead Sponsor Class:
OTHER
Responsible Party:
Jeffrey Raizer
Responsible Party Title:
Jeffrey Raizer MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Northwestern University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |